PharmaBoardroom

Interview: Dr. Leisha Daly – Country Director, Janssen;…

Dr. Leisha Daly, Janssen Ireland country director and president of the Irish Pharmaceutical Healthcare Association (IPHA) discusses her presidency and…

Hungary Biotech Cluster Map

Hungary's medicinal biotech companies are clustered in the country's four major university towns: Budapest, Debrecen, Szeged and Pécs, with the…

Interview: Daniel Breitenstein – Vice President &…

Daniel Breitenstein, VP and GM of GSK Switzerland, discusses the benefits of GSK’s three-part transaction with Novartis; the importance of…

Interview: Ludo Ooms – Managing Director…

Janssen Switzerland’s Ludo Ooms highlights the strengths of the Swiss healthcare and life sciences sector including the efficiency of the…

French Pharma Map

This map shows the overall contribution of the pharmaceutical industry to the French economy, including number of employees by region, investment…

Singapore’s Recipe for Success

Singapore, though conscious of its limitations, has been able to leverage its key assets of location, infrastructure and local talent in order to…

Interview: Daniel Pardo Bejarano – CEO, BOMI Mexico

Daniel Pardo Bejarano, CEO of BOMI Mexico, details the competitive advantages and the unique business approach that make BOMI the logistics partner of…

Interview: Matt Moran – Director, BioPharmaChem, Ireland

With nearly €4 billion of capital investment in large molecule manufacturing underway, Ireland’s strategy to become a premier destination for…

Italy Pharma Map

The following map shows the importance of the pharmaceutical industry to the highly regionalised Italian industry. Lombardy in the North of Italy…

Interview: Dr. Siew Hwa Ong – Chairman, BioSingapore

The chairman of BioSingapore, Dr. Siew Hwa Ong, discusses the opportunities and challenges facing biotech SMEs in Singapore, government efforts to…

Interview: Teodoro Padilla – Executive Director; Reiner…

Teodoro Padilla, Executive Director at the Pharmaceutical and Healthcare Association of the Philippines, and Reiner Gloor, Advisor and…

Sources of R&D Investment in Italy

The below chart shows the sources of funding for R&D investment in Italy, with only 7% of total investment originating from pharmaceutical and…

Tagged with ARM